Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

NCT04145375 is registered in ClinicalTrials.gov with Zenith Epigenetics as lead sponsor.

NCT NCT04145375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04145375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
Lead sponsor
Zenith Epigenetics
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
November 12, 2019
Completion date
December 31, 2027
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mcrpc